Jyoti Gogoi

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

UAMS

Unknown Researcher

1 h-index 4 pubs 17 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Jyoti Gogoi's research investigates the pharmacological effects and potential toxicity of various compounds, with a recent focus on synthetic cannabinoids and plant-derived substances. Gogoi has published work examining the genotoxic suppressant effects of compounds from *Paederia foetida* and *Terminalia arjuna* on the *Allium cepa* model. Additionally, research has explored the metabolic fate and receptor interactions of synthetic cannabinoids, such as 5F-ADB, to understand their potential contribution to enhanced toxicity. Gogoi collaborates with researchers at the University of Arkansas for Medical Sciences, including William E. Fantegrossi and Paul L. Prather, with whom they share co-authored publications. Gogoi's scholarly output includes four publications with 17 citations and an h-index of 1.

Metrics

h-index: 1
Publications: 4
Citations: 17

Selected Publications

Major Metabolites of the Synthetic Cannabinoid 5F‐ADB Retain High Affinity and Full Efficacy at CB1 Receptors; Potential Mechanism Contributing to Enhanced Toxicity? (2021)

The FASEB Journal DOI OpenAlex
Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity (2020)

Pharmacology Biochemistry and Behavior 17 citations DOI OpenAlex
Pharmacological Characterization of Synthetic Cannabinoid MAM‐2201: Radioligand Binding and Abuse‐Related Effects (2018)

The FASEB Journal DOI OpenAlex